ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago

scientific article (publication date: October 2002)

ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1016605420
P356DOI10.1007/S00439-002-0816-1
P698PubMed publication ID12384782

P50authorPatrick SheaQ42862061
Lewis KullerQ88077314
P2093author name stringRobert E Ferrell
Clareann H Bunker
Alan L Patrick
P433issue4-5
P407language of work or nameEnglishQ1860
P921main subjectprostate cancerQ181257
P304page(s)398-400
P577publication date2002-10-01
P1433published inHuman GeneticsQ5937167
P1476titleELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago
P478volume111

Reverse relations

cites work (P2860)
Q36417303African-Caribbean cancer consortium for the study of viral, genetic and environmental cancer risk factors
Q33898895Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases
Q41880985ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies
Q28236488ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells
Q35597290Genetic polymorphisms and prostate cancer risk
Q28185500HPC2/ELAC2 gene variants associated with incident prostate cancer
Q33986279Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up Study

Search more.